What the Options Market Tells Us About Novo Nordisk
What the Options Market Tells Us About Novo Nordisk
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 14 unusual trades.
金融巨头对诺和诺德采取了明显的看跌举动。我们对诺和诺德（纽约证券交易所代码：NVO）期权历史的分析显示了14笔不寻常的交易。
Delving into the details, we found 35% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $210,005, and 9 were calls, valued at $379,290.
深入研究细节，我们发现35％的交易者看涨，而50％的交易者表现出看跌的趋势。在我们发现的所有交易中，有5笔是看跌期权，价值210,005美元，9笔是看涨期权，价值379,290美元。
Predicted Price Range
预测的价格区间
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $111.0 for Novo Nordisk over the last 3 months.
考虑到这些合约的交易量和未平仓合约，在过去的3个月中，鲸鱼似乎一直将Novo Nordisk的价格定在105.0美元至111.0美元之间。
Insights into Volume & Open Interest
对交易量和未平仓合约的见解
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $105.0 to $111.0, over the past month.
检查交易量和未平仓合约为股票研究提供了至关重要的见解。这些信息是衡量Novo Nordisk期权在特定行使价下的流动性和利息水平的关键。下面，我们简要介绍了过去一个月诺和诺德重大交易的看涨期权和未平仓合约的趋势，行使价区间为105.0美元至111.0美元。
Novo Nordisk 30-Day Option Volume & Interest Snapshot
Novo Nordisk 30 天期权交易量和利息快照
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | NEUTRAL | 12/13/24 | $5.6 | $5.05 | $5.29 | $105.00 | $159.0K | 171 | 300 |
| NVO | PUT | TRADE | NEUTRAL | 12/20/24 | $8.35 | $8.0 | $8.2 | $110.00 | $42.6K | 7.0K | 273 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 116 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 64 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $7.7 | $7.5 | $7.5 | $109.00 | $42.0K | 351 | 56 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 打电话 | 扫 | 中立 | 12/13/24 | 5.6 美元 | 5.05 美元 | 5.29 美元 | 105.00 美元 | 159.0K | 171 | 300 |
| NVO | 放 | 贸易 | 中立 | 12/20/24 | 8.35 美元 | 8.0 美元 | 8.2 美元 | 110.00 美元 | 42.6 万美元 | 7.0K | 273 |
| NVO | 放 | 贸易 | 看涨 | 12/20/24 | 8.2 美元 | 8.1 美元 | 8.1 美元 | 110.00 美元 | 42.1 万美元 | 7.0K | 116 |
| NVO | 放 | 贸易 | 看涨 | 12/20/24 | 8.2 美元 | 8.1 美元 | 8.1 美元 | 110.00 美元 | 42.1 万美元 | 7.0K | 64 |
| NVO | 放 | 贸易 | 看涨 | 12/20/24 | 7.7 美元 | 7.5 美元 | 7.5 美元 | 109.00 美元 | 42.0 万美元 | 351 | 56 |
About Novo Nordisk
关于 Novo Nordisk
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
诺和诺德拥有全球品牌糖尿病治疗市场约三分之一的份额，是全球领先的糖尿病护理产品提供商。该公司总部位于丹麦，生产和销售各种人用和现代胰岛素、注射型糖尿病治疗药物（如 GLP-1 疗法）、口服抗糖尿病药物和肥胖疗法。Novo还有一个生物制药板块（约占收入的10％），专门研究血友病和其他疾病的蛋白质疗法。
Where Is Novo Nordisk Standing Right Now?
诺和诺德现在处于什么位置？
- Trading volume stands at 358,592, with NVO's price down by -0.65%, positioned at $105.44.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 61 days.
- 交易量为358,592美元，其中NVO的价格下跌了-0.65％，为105.44美元。
- RSI指标显示，该股目前在超买和超卖之间处于中立状态。
- 预计将在61天内公布财报。
Expert Opinions on Novo Nordisk
关于诺和诺德的专家意见
1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.
1位市场专家最近发布了该股的评级，共识目标价为160.0美元。
Unusual Options Activity Detected: Smart Money on the Move
检测到不寻常的期权活动：智能货币在移动
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160.
Benzinga Edge的不寻常期权委员会在潜在的市场推动者发生之前就发现了它们。看看大笔资金对你最喜欢的股票持有哪些头寸。点击此处查看。* 坎托·菲茨杰拉德的一位分析师将其股票评级下调至增持，目标股价为160美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
与仅交易股票相比，期权是一种风险更高的资产，但它们具有更高的获利潜力。严肃的期权交易者通过每天自我教育、扩大交易规模、关注多个指标以及密切关注市场来管理这种风险。
